Second-generation direct-acting-antiviral hepatitis C virus treatment: Efficacy, safety, and predictors of SVR12

AIM: To gather data on the antiviral efficacy and safety of second generation direct acting antiviral (DAA) treatment with respect to sustained virological response (SVR) 12 wk after conclusion of treatment, and to determine predictors of SVR12 in this setting. METHODS: Two hundred and sixty patient...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:World J Gastroenterol
Hlavní autoři: Werner, Christoph R, Schwarz, Julia M, Egetemeyr, Daniel P, Beck, Robert, Malek, Nisar P, Lauer, Ulrich M, Berg, Christoph P
Médium: Artigo
Jazyk:Inglês
Vydáno: Baishideng Publishing Group Inc 2016
Témata:
Retrospective Cohort Study
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5028818/
https://ncbi.nlm.nih.gov/pubmed/27672299
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v22.i35.8050
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky